Garimer Rodriguez is a Miami, Florida based nurse practitioner. Active license number of Garimer Rodriguez is APRN11032227 for Family in Florida. His current practice location is 4112 Sw 90th Ct, Miami. Patients can reach him at 786-638-9855. Garimer Rodriguez is APRN and his NPI number (Unique professional ID assigned by NPPES) is 1366254393. Garimer Rodriguez has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Garimer Rodriguez speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1366254393
NPI Enumeration Date:
27 Jan, 2025
NPI Last Update On:
27 Jan, 2025
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Garimer Rodriguez are as mentioned below.
License Number
Specialization
State
Status
APRN11032227
Family
Florida
Primary
RN9617823
Registered Nurse
Florida
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Garimer Rodriguez 4112 Sw 90th Ct, Miami, Florida
Zip:
33165-5359
Phone Number:
786-638-9855
Patients can reach Garimer Rodriguez at 4112 Sw 90th Ct, Miami, Florida or can call to book an appointment on 786-638-9855.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 10 February, 2025.